Matthew Read comments on CYN refresh

Biotech trusts top performance charts in February

Matthew Read comments on Keith Watson and Robert Crayfourd retaking the helm at CYN in Jack Roach’s article:

“We think CYN shareholders will be pleased to see Watson and Crayfourd back at the helm of the portfolio and glad that the period of uncertainty following their departure from CQS is now over.”

Read the article here